SCHEMBL3199280

SCHEMBL3199280

CCOC(=O)Cc1ccc(N(Cc2cncnc2)c2ccc(OC(F)F)c(OC(F)F)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.36
DHFR P00374 2/20 0.36
CYP4Z1 Q86W10 1/20 0.35
MAOB P27338 1/20 0.35
PDE4A P27815 2/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
SYK P43405 1/20 0.33
FBP1 P09467 1/20 0.33
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
TBXAS1 P24557 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129231 0.92 PDE4B (0.38) PDE4BDHFRMAOBPDE4APDE4C
SCHEMBL3122279 0.90 ALDH1A1 (0.43) PDE4BDHFRPDE4APDE4CPDE4D
SCHEMBL3210508 0.87 TRPM8 (0.37) PDE4BDHFRCYP4Z1MAOBPDE4A
SCHEMBL3128465 0.87 PDE4A (0.44) PDE4BPDE4APDE4CPDE4DGAA
SCHEMBL3215675 0.85 GAA (0.38) DHFRCYP4Z1MAOBL3MBTL1SYK
SCHEMBL3129693 0.83 GRM2 (0.44) PDE4BALDH1A1MAPTKMT2ALMNA
SCHEMBL3203252 0.83 HRH4 (0.40) PDE4BDHFRCYP4Z1MAOBPDE4A
SCHEMBL3133720 0.83 PDE4A (0.41) PDE4BPDE4APDE4CPDE4DSMN1; SMN2
SCHEMBL3129586 0.81 PDE4A (0.45) PDE4BPDE4APDE4CPDE4D
SCHEMBL3123416 0.80 RXRA (0.44) PDE4BPDE4APDE4CPDE4DL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B PDE4B 2/4885DHFR 214/4885CYP4Z1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.